Seeking AlphaThu, 18 Jun 2026 18:02:18 GMTC4 Therapeutics, Inc. (CCCC) Discusses Evolving Multiple Myeloma Treatments and the Role of IKZF1/3 Degraders Including Cemsidomide TranscriptCCCC+1.76%
Zacks Investment ResearchThu, 18 Jun 2026 14:41:12 GMTAre Medical Stocks Lagging C4 Therapeutics (CCCC) This Year?CCCC+1.76%
Seeking AlphaTue, 02 Jun 2026 14:58:12 GMTC4 Therapeutics "Buy" On Cemsidomide Advancement And Competitor's Positive ReadoutCCCC+1.76%
Zacks Investment ResearchMon, 01 Jun 2026 17:02:11 GMTC4 Therapeutics (CCCC) Upgraded to Buy: What Does It Mean for the Stock?CCCC+1.76%
Zacks Investment ResearchFri, 15 May 2026 14:41:32 GMTAre Medical Stocks Lagging C4 Therapeutics (CCCC) This Year?CCCC+1.76%
Zacks Investment ResearchTue, 12 May 2026 13:11:05 GMTC4 Therapeutics, Inc. (CCCC) Reports Q1 Loss, Lags Revenue EstimatesCCCC+1.76%
